β3-Adrenergic Receptor Agonism Reduces Right Ventricular Systolic Pressure in a Preclinical Model of Heart Failure With Preserved Ejection Fraction-Associated Pulmonary Hypertension

J Cardiovasc Pharmacol Ther. 2026 Jan-Dec;31:10742484261495417. doi: 10.1177/10742484261495417. Epub 2026 Oct 18.ABSTRACTPurposePulmonary hypertension (PH) commonly complicates heart failure with preserved ejection fraction (HFpEF), driving morbidity and mortality, yet no therapies exist for HFpEF-P

C Christelle Lteif

Endothelial dysfunction and long-term survival in cardiovascular-kidney-metabolic syndrome stages 0-3: An EASIX-based national cohort study

Sci Prog. 2026 Oct-Dec;109(4):368504261499186. doi: 10.1177/00368504261499186. Epub 2026 Oct 18.ABSTRACTObjectiveTo assess the association of the endothelial activation and stress index (EASIX) with all-cause and cardiovascular mortality in adults at cardiovascular-kidney-metabolic (CKM) syndrome st

A Asiya Abudesimu

How relationships with exercise change: A qualitative study on the influences of exercise decision-making with systemic lupus erythematosus and cardiovascular disease

Lupus. 2026 Oct 18:9612033261499215. doi: 10.1177/09612033261499215. Online ahead of print.ABSTRACTBackground: Greater than 50% of individuals with systemic lupus erythematosus (SLE) will develop cardiovascular disease (CVD). Moderate-intensity aerobic exercise significantly reduces CVD risk, morbid

M Melissa J Frederick

Cardiology Support Utilization Patterns and Associated Barriers Across Northwestern Ontario

Healthc Manage Forum. 2026 Oct 18:8404704261492943. doi: 10.1177/08404704261492943. Online ahead of print.ABSTRACTThe Thunder Bay Regional Health Sciences Centre On-Call Cardiology Support Service serves a geographically vast region across Northwestern Ontario where cardiovascular disease is a major

J Jamal Al-Atawneh

The "living well with lupus" lifestyle intervention: Effects on gut microbiota in patients with systemic lupus erythematosus and high cardiovascular risk

Lupus. 2026 Oct 18:9612033261496128. doi: 10.1177/09612033261496128. Online ahead of print.ABSTRACTBackgroundSystemic lupus erythematosus (SLE) is an autoimmune disease associated with increased cardiovascular risk and gut microbiota dysbiosis. Although lifestyle can modulate the microbiome, the imp

M Marina Alvarenga Romero

Association of peripartum cardiomyopathy with psychiatric disorders - a narrative review

Psychiatr Pol. 2025 Oct 20:1-11. doi: 10.12740/PP/OnlineFirst/207884. Online ahead of print.ABSTRACTPeripartum cardiomyopathy (PPCM) is a myocardial disease characterized by a decrease in left ventricular ejection fraction below 45%, developing at the end of pregnancy or within a few months after it

B Bartosz Bula

Patterns of cardiovascular disease subtypes and associated factors among young adults in Peshawar, Pakistan: a multicenter hospital-based cross-sectional study

Future Cardiol. 2026 Oct 18:1-7. doi: 10.1080/14796678.2026.2739742. Online ahead of print.ABSTRACTBACKGROUND: Cardiovascular diseases (CVDs) are a major cause of morbidity and mortality. Evidence on CVD subtypes in young Pakistani adults is limited. This study characterized CVD subtypes and associa

N Nauman Arif

Absent right pulmonary artery with patent ductus arteriosus and Eisenmenger syndrome

No abstractEur Heart J Imaging Methods Pract. 2026 Sep 30;4(4):qyag169. doi: 10.1093/ehjimp/qyag169. eCollection 2026 Oct.NO ABSTRACTPMID:42893297 | PMC:PMC13676300 | DOI:10.1093/ehjimp/qyag169

J José Martín Alanís-Naranjo

Impact of an integrated hospital-community care pathway on the management of venous thromboembolism: the venous thromboembolic disease care pathway 93 study

Res Pract Thromb Haemost. 2026 Sep 12;10(7):106956. doi: 10.1016/j.rpth.2026.106956. eCollection 2026 Oct.ABSTRACTBACKGROUND: Venous thromboembolism (VTE) carries a high risk of recurrence and bleeding complications. Care transitions represent a vulnerable period, particularly in medically underserv

J Jérémy Datchanamourty

Endothelium-targeted and untargeted nanoparticle therapies in thromboinflammatory vascular diseases

Blood Vessel Thromb Hemost. 2026 Sep 2;3(4):100210. doi: 10.1016/j.bvth.2026.100210. eCollection 2026 Nov.ABSTRACTEndothelial cells (ECs) line the vasculature and integrate hemodynamic, inflammatory, and metabolic cues that are crucial in maintaining vascular health. Endothelial dysfunction is a dri

M Micheal O Avoseh

Pro-inflammatory cytokines moderated by visceral adiposity from a pragmatic randomized crossover trial of portable HEPA air purifiers

Am J Prev Cardiol. 2026 Jul 28;31:101775. doi: 10.1016/j.ajpc.2026.101775. eCollection 2027 Jan.ABSTRACTBACKGROUND: Airborne particulate matter (PM) increases the risk of cardiovascular disease. High efficiency particulate arrestance (HEPA) filtration can reduce indoor PM, but evidence is lacking as

D Doug Brugge

Association of adverse pregnancy outcomes with coronary microvascular dysfunction: a systematic review and meta-analysis

Am J Prev Cardiol. 2026 Jun 1;31:101692. doi: 10.1016/j.ajpc.2026.101692. eCollection 2027 Jan.ABSTRACTBACKGROUND: Adverse pregnancy outcomes (APOs) are recognized cardiovascular risk enhancers, yet their association with coronary microvascular dysfunction (CMD) has not been systematically quantifie

S Syeda Beenish Bareeqa

Implementing Lp(a) Screening in Veterans Affairs and Safety Net Settings: A Dual Site Pilot Quality Improvement Initiative

No abstractAm J Prev Cardiol. 2026 Jul 31;31:101777. doi: 10.1016/j.ajpc.2026.101777. eCollection 2027 Jan.NO ABSTRACTPMID:42893210 | PMC:PMC13676079 | DOI:10.1016/j.ajpc.2026.101777

E Erfan Tasdighi

Lipoprotein(a) as a cardiovascular risk accelerator in primary prevention: Age-equivalent risk and event-free survival at 10 years in the UK biobank

No abstractAm J Prev Cardiol. 2026 Jun 18;31:101706. doi: 10.1016/j.ajpc.2026.101706. eCollection 2027 Jan.NO ABSTRACTPMID:42893209 | PMC:PMC13676061 | DOI:10.1016/j.ajpc.2026.101706

A Arturo Cesaro

Carotid atherosclerosis and aortic stiffness in masters athletes: Multimodality vascular phenotyping from the Master@Heart study

Am J Prev Cardiol. 2026 Jul 25;31:101771. doi: 10.1016/j.ajpc.2026.101771. eCollection 2027 Jan.ABSTRACTBACKGROUND: Middle-aged male Masters athletes exhibit a higher burden of coronary atherosclerosis on coronary computed tomography angiography (CCTA) compared with healthy controls. Whether this is

R Rik Pauwels

Heavy menstrual bleeding in women with a bleeding disorder of unknown cause: a common symptom impacting daily life functioning

Res Pract Thromb Haemost. 2026 Sep 8;10(6):106950. doi: 10.1016/j.rpth.2026.106950. eCollection 2026 Aug.ABSTRACTBACKGROUND: Persons with an increased bleeding tendency without abnormalities in standard hemostasis tests are classified as having a bleeding disorder of unknown cause (BDUC). The majori

C Caroline M A Mussert

A biomarker risk score predicts adverse cardiovascular outcomes in patients with angina and non-obstructive coronary artery disease

No abstractAm J Prev Cardiol. 2026 Jun 10;31:101701. doi: 10.1016/j.ajpc.2026.101701. eCollection 2027 Jan.NO ABSTRACTPMID:42893189 | PMC:PMC13676059 | DOI:10.1016/j.ajpc.2026.101701

J Jingwen Huang

Epicardial adipose tissue radiomics complement calcium scoring in black adults with type 2 diabetes mellitus

Am J Prev Cardiol. 2026 Jun 1;31:101693. doi: 10.1016/j.ajpc.2026.101693. eCollection 2027 Jan.ABSTRACTBACKGROUND: Conventional markers of risk such as coronary artery calcium (CAC) scores are lower and less predictive in Black adults, despite a high prevalence of Type 2 diabetes mellitus (T2DM) and

R Robert Okyere

Heart failure and atrial fibrillation prediction from non-gated chest CT scans using AI-based cardiac chamber volumetry: an AI-CVD study within the multi-ethnic study of atherosclerosis (MESA)

Am J Prev Cardiol. 2026 Jul 5;31:101732. doi: 10.1016/j.ajpc.2026.101732. eCollection 2027 Jan.ABSTRACTBACKGROUND: We previously demonstrated that AI-derived cardiac chamber volumetry in ECG-gated CT scans predicts atrial fibrillation (AF) and heart failure (HF). Since most chest CTs are non-gated,

S Seyed Reza Mirjalili

Temporal changes in lipoprotein(a) after acute coronary syndrome

Am J Prev Cardiol. 2026 Aug 28;31:101723. doi: 10.1016/j.ajpc.2026.101723. eCollection 2027 Jan.ABSTRACTBACKGROUND AND AIMS: Lipoprotein(a) [Lp(a)] is an established independent risk factor for atherosclerotic cardiovascular disease and is traditionally considered stable. Its behavior following acut

C Christelle Lattouf

Sex differences in psychosocial burden and healthcare access among U.S. adults with premature atherosclerotic cardiovascular disease

No abstractAm J Prev Cardiol. 2026 Jul 17;31:101751. doi: 10.1016/j.ajpc.2026.101751. eCollection 2027 Jan.NO ABSTRACTPMID:42893176 | PMC:PMC13676047 | DOI:10.1016/j.ajpc.2026.101751

N Niti Dalal

Absence of significant coronary artery disease does not eliminate smoking-related cardiovascular risk: insights from the PROMISE trial

Am J Prev Cardiol. 2026 Jul 11;31:101740. doi: 10.1016/j.ajpc.2026.101740. eCollection 2027 Jan.ABSTRACTBACKGROUND: Although the relationship between smoking and cardiovascular events is well established, it remains uncertain whether the outcomes of noninvasive testing (NIT) influence this relations

N Nóra M Kerkovits

C-reactive protein and mortality in 'SMuRF-less but inflamed' women and men: Evidence from the United Kingdom Biobank

No abstractAm J Prev Cardiol. 2026 Jun 25;31:101715. doi: 10.1016/j.ajpc.2026.101715. eCollection 2027 Jan.NO ABSTRACTPMID:42893168 | PMC:PMC13676050 | DOI:10.1016/j.ajpc.2026.101715

F Florian Kahles

De-escalating Therapy in Obstructive Sleep Apnoea After Glucagon-Like Peptide-1 Receptor Agonist-Induced Weight Loss: A Narrative Review

Cureus. 2026 Sep 17;18(9):e116412. doi: 10.7759/cureus.116412. eCollection 2026 Sep.ABSTRACTIncretin-based therapies now achieve weight reduction of a magnitude previously attainable only through bariatric surgery and have demonstrated substantial reductions in the apnoea-hypopnoea index (AHI) in ad

W Wares Jalil